EPH75 Adverse Event Types and Discontinuation Rate of Alzheimer's Medication Approved by United States Food and Drug Administration (USFDA)
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.1117
https://www.valueinhealthjournal.com/article/S1098-3015(23)04247-X/fulltext
Section Title :
Section Order :
10599
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04247-X&doi=10.1016/j.jval.2023.09.1117